Dr Maria Cascio

Biography

I graduated in July 2002 in Chemistry and Pharmaceutical Technologies (Master degree-UK equivalent) from the University of Palermo (Italy), obtaining the highest mark possible under the system (110/110 cum laude).

From September 2000 to June 2007 I was based in Naples where I joined the “Endocannabinoid Research Group”, at the National Council of Research. There, I started my research aimed at understanding the involvement of the “Endocannabinoid System” in both pathological and physiological conditions.

In 2006 I obtained my PhD in Pharmaceutical Chemistry (University of Fisciano, Salerno, Italy).

In 2007, I moved to the University of Aberdeen and as Research Fellow (supported by GW Pharmaceuticals) I have been involved, in collaboration with Professor Roger Pertwee, in the pharmacological in vitro characterization of new Cannabis-derived cannabinoids. In 2014 I was promoted to Research Fellow, Grade 7 (Lecturer grade).

I am co-author of more than 80 peer-reviewed papers and 6 book chapters. You can see my publications here:

http://www.ncbi.nlm.nih.gov/pubmed/?term=Cascio+MG

Currently, I am University Senior Equality, Diversity and Inclusion Partner supporting work aimed at addressing the barriers faced by underrepresented groups.  If you wish to get in touch, please email me! m.cascio@abdn.ac.uk

Research Overview

Main research interests are:

. Medicinal chemistry

. Pharmacology and therapeutic potential of plant cannabinoids

· Pharmacology of allosteric sites on cannabinoid receptors

·  Novel cannabinoid CB₁ and CB₂ receptor ligands

·  New pharmacological targets for cannabinoids

·  Roles of the endocannabinoid system in health and disease

. Anti-proliferative effects of the omega 3 fatty acids/ethanolamides in prostate cancer

Technical Experience

Biochemistry assays: Western Blotting, PCR, Plasmid Transfection, Lipid extraction from tissues and cells.

Immunofluorimetric assays: p-ERK 1/2 AlphaScreen^®, SureFire^® (Envision, Perkin Elmer), E.L.I.S.A., cyclic AMP, β-arrestin.

Pharmacological assay: [³⁵S]GTPγS binding, [³H]Displacement binding, Impedance-based system (RT-CES^®) for dynamic monitoring of GPCRs activation in living cells.

Chromatography (Silica gel and HPLC).

Cells culturing

Simple synthesis of chemical tools

Current Research

Maria Grazia Cascio's current research is directed at elucidating the pharmacological actions of plant cannabinoids such as cannabidiol (CBD), delta-9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG). In addition, she is currently involved in projects aimed at identifying new potent and selective ligands for the cannabinoid CB1 and CB2 receptors. For this she is collaborating with chemists based in Italy.

My research also focuses on the study of the anti-proliferative effects of two fish oil omega 3 fatty acids (DHA and EPA) and their ethanolamides (DHEA and EPEA) in two prostate cancer cell lines, PC3 and LNCaP.

Collaborations

Internal collaborators

Dr Iain Brown (Project: Prostate cancer)

Professor Matteo Zanda (Project: New CB₁ ligands for PET)

Dr Mirela Delibegovic (Project: The study of the involvement of the endocannabinoid system in diabetic nephropathy).

External collaborators

Dr Ben Whalley, University of Reading (Project: The anticonvulsant properties of some plant-derived cannabinoids);

Professor Angelo Izzo, University “Federico II” of Naples (Project: The ability of some plant-derived cannabinoids to ameliorate murine colitis;

Professor Daniela Parolaro, University of Milan (Project: The ability of some plant-derived cannabinoids to ameliorate schizophrenia);

Dr Barbara Costa, University of Busto Arstizio (Project: Investigation of the analgesic properties of the plant-derived cannabigerol),

Dr Ganesh Takhur, (Department of Pharmaceutical Sciences, Northeastern University, Boston) (Project: Investigation of the pharmacological profile of new synthetic CB₁ cannabinoid receptor Positive Allosteric Modulators);

Professor Federico Corelli and Dr Antonella Brizzi, (University of Siena),

Professor Giovanni Appendino (University of Novara);

Professor Romano Silvestri and Professor Giorgio Ortar (University of Rome).

Funding and Grants

Delibegovic M, Cascio MG and Pertwee RG. Diabetes. Eighteen months (2014-2016). 

Takhur G, Cascio MG, Pertwee RG et al.,. NIDA. Five years (2014 to 2019).

Pertwee RG and Cascio MG. Honours Student Project, 10 weeks (January 2014 - March 2014), University of Aberdeen, 

Cascio MG. Summer student from Brazil, 3 months (June 2013 - August, 2013), University of Aberdeen, 

Cascio MG, Marini P, Brown I, Pertwee R.G. NHS Grampian Endowment Research Fund, Scotland, UK. One year (April 2013- March 2014). .

Brown I, Cascio MG, Sneddon AA, Wahle KWJ, Pertwee RG, Heys SD. Fraserburgh Moonlight Prowl and University of Aberdeen. PhD studentship in Nutrition and Cancer. Three years (2010 to 2013). Student stipend, home/EU fees and consumables.

Cascio MG and Pertwee RG. Honours Student Project, 10 weeks (January 2012 - March 2012), University of Aberdeen, 

Brown I, Cascio MG, Heys SD, Pertwee RG. & Ross RA. Tenovus Scotland. One year (April 2010-March 2011). 

Brown I, Cascio MG. & Pertwee RG.  NHS GRAMPIAN ENDOWMENTS. One year (April 2010-March 2011). 

Teaching Responsibilities

Supervisor of both undergraduate and PhD students

Student tutor in Life Sciences subjects